Abstract Number: 174 • 2019 ACR/ARP Annual Meeting
Clinical Presentation and Disease Course Evaluation of Mono- and Bilateral Knee Arthritis: Results from the Leiden Early Arthritis Clinic Cohort
Background/Purpose: Patients presenting with arthritis in one or both knees propose a challenge regarding diagnosis, prognosis and treatment decisions. The aim of the current study…Abstract Number: 1535 • 2018 ACR/ARHP Annual Meeting
Enhancing Patient Ability to Process and Use Information about Medication Risks and Benefits
Background/Purpose: Guidelines for the treatment of rheumatoid arthritis (RA) underscore the importance of an early and targeted approach to control inflammation. However, patients are often…Abstract Number: 1551 • 2018 ACR/ARHP Annual Meeting
Anti-Drug Antibodies to Certolizumab Pegol Are Assiciated with Low Drug Levels and Reduced Clinical Response at 3 Months in Patients with Inflammatory Joint Diseases
Background/Purpose: Anti-drug antibodies (ADAb) to biological drugs predispose patients (pts) to low drug levels and lack of treatment response. For certolizumab pegol (CP) knowledge about…Abstract Number: 309 • 2017 ACR/ARHP Annual Meeting
Compression Assisted Arthrocentesis and Intraarticular Injection
Background/Purpose: We hypothesized that compression assisted arthrocentesis of the knee would improve arthrocentesis fluid yields and intraarticular injection outcomes.Methods: We performed conventional arthrocentesis on 215…Abstract Number: 1004 • 2017 ACR/ARHP Annual Meeting
Arthritis Impact at the State and County Level — United States, 2015
Background/Purpose: Arthritis, a leading cause of disability, affects 54.4 million US adults. By knowing the state and county level arthritis impact, state-level public health professionals…Abstract Number: 1955 • 2017 ACR/ARHP Annual Meeting
Health Care Provider Advice for Weight Loss Among US Adults with Arthritis, National Health Interview Survey, 2014
Background/Purpose: Most clinical practice guidelines for the management of osteoarthritis recommend weight loss for adults with arthritis who are overweight or obese. A health care…Abstract Number: 2260 • 2017 ACR/ARHP Annual Meeting
Communication Strategies Are Highly Important to Avoid Nocebo Effect When Performing Non-Medical Switch from Originator Product to Biosimilar Product: Danish Results from Applying the Parker Model a Qualitative 3-Step Research Model
Background/Purpose: Introducing a non-medical switch from originator to a biosimilar product in the management of chronic arthritis, i.e. switching patients in remission or low disease…Abstract Number: 2822 • 2017 ACR/ARHP Annual Meeting
A Randomized Controlled Effectiveness Trial of the Enhance-Fitness® Physical Activity Program in People with Arthritis
Background/Purpose: EnhanceFitness® (EF) is an evidence-based, community-delivered intervention for older adults; however, its effectiveness in people with arthritis is unknown. The purpose of this pragmatic,…Abstract Number: 480 • 2016 ACR/ARHP Annual Meeting
Local Cryotherapy Down-Regulates Local and Systemic IL-6/IL-17 Pathway with No Effect on TNF-α in Adjuvant-Induced Arthritis
Background/Purpose: Cryotherapy is widely and empirically used in an adjuvant and symptomatic setting in inflammatory rheumatic diseases, with a low level of evidence [1]. The aim…Abstract Number: 1249 • 2016 ACR/ARHP Annual Meeting
“There Are Still a Lot of Things That I Need”: A Qualitative Study Exploring Opportunities to Improve the Health Outcomes of First Nations People with Arthritis Seen at an on-Reserve Outreach Rheumatology Clinic
Background/Purpose: A rheumatology specialty clinic embedded in a primary health care clinic on a First Nations reserve was established six years ago to improve access…Abstract Number: 1737 • 2016 ACR/ARHP Annual Meeting
Adherence to Subcutaneous Biological Therapies Among Inflammatory Arthropaty Patients from a University Hospital
Background/Purpose: Rheumatic inflammatory arthropaties such as Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) and Spondyloarthrities (SpA) are chronic diseases that require adequate therapies, sometimes biological drugs,…Abstract Number: 2386 • 2015 ACR/ARHP Annual Meeting
Integrating Wearable Physical Activity Monitoring Tools into Rehabilitation Practice for Patients with Arthritis: The Healthcare Professional Perspective
Background/Purpose: Wearable physical activity monitoring tools can be used for goal-setting and progress-monitoring in rehabilitation programs for patients with arthritis. Little is known about the…Abstract Number: 2496 • 2015 ACR/ARHP Annual Meeting
Telerheumatology: A Technology Not Appropriate for All
Title: Telerheumatology: A Technology Not Appropriate For AllBackground/Purpose: Access to Rheumatology care in New Hampshire (NH) and Vermont (VT) is limited, as a large proportion…Abstract Number: 2524 • 2015 ACR/ARHP Annual Meeting
Longterm Follow-up of Children Born to Mothers with Chronic Arthritides and Exposed to Anti-TNF Alfa Agents during Pregancy and Breastfeeding: A Case-Control Study
Background/Purpose: Anti-TNFalfa agents have been used to control disease activity of patients with Chronic Arthritides (Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis) during the wash-out period…Abstract Number: 2565 • 2015 ACR/ARHP Annual Meeting
ACPA Specific IVIG Attenuate Collagen Induced Arthritis in Mice
Background/Purpose: Administration of intravenous-immunoglobulin (IVIg) is a recognized safe and efficient immunomodulatore therapy for many autoimmune diseases. Anti-idiotypic antibody binding to pathogenic autoantibodies was proposed…